Female Breast Cancer, Stage of Disease at Diagnosis by Year, Public Health Districts, 2003-2010
Public Health District I
2003^
Stage at
Diagnosis
White Females Black Females
In Situ 20.6% 13.0%
Localized 52.7% 40.7%
Regional 21.4% 38.9%
Distant 3.1% 3.7%
Unknown 2.3% 3.7%
2004
Stage at
Diagnosis
White Females Black Females
In Situ 16.0% 10.9%
Localized 48.1% 34.5%
Regional 29.0% 34.5%
Distant 3.1% 9.1%
Unknown 3.8% 10.9%
2005
Stage at
Diagnosis
White Females Black Females
In Situ 22.4% 5.9%
Localized 37.2% 27.5%
Regional 35.3% 45.1%
Distant 4.5% 7.8%
Unknown 0.6% 13.7%
2006
Stage at
Diagnosis
White Females Black Females
In Situ 18.9% 24.2%
Localized 41.9% 35.5%
Regional 29.1% 29.0%
Distant 6.1% 8.1%
Unknown 4.1% 3.2%
2007
Stage at
Diagnosis
White Females Black Females
In Situ 21.1% 19.4%
Localized 38.5% 17.9%
Regional 32.3% 44.8%
Distant 4.3% 13.4%
Unknown 3.7% 4.5%
2008
Stage at
Diagnosis
White Females Black Females
In Situ 14.0% 12.3%
Localized 52.4% 35.1%
Regional 28.0% 40.4%
Distant 2.8% 8.8%
Unknown 2.8% 3.5%
2009
Stage at
Diagnosis
White Females Black Females
In Situ 21.4% 15.6%
Localized 51.8% 32.8%
Regional 23.2% 39.1%
Distant 3.0% 4.7%
Unknown 0.6% 7.8%
2010
Stage at
Diagnosis
White Females Black Females
In Situ 22.4% 10.0%
Localized 48.0% 34.3%
Regional 17.8% 47.1%
Distant 3.9% 5.7%
Unknown 7.9% 2.9%
Public Health District II
2003^
Stage at
Diagnosis
White Females Black Females
In Situ 13.6% 25.0%
Localized 53.4% 53.1%
Regional 31.3% 18.8%
Distant 0.6% 3.1%
Unknown 1.1% 0.0%
2004
Stage at
Diagnosis
White Females Black Females
In Situ 14.4% 12.8%
Localized 50.2% 20.5%
Regional 29.2% 53.8%
Distant 4.8% 10.3%
Unknown 1.4% 2.6%
2005
Stage at
Diagnosis
White Females Black Females
In Situ 13.5% 16.7%
Localized 51.8% 44.4%
Regional 27.5% 29.6%
Distant 5.0% 7.4%
Unknown 2.3% 1.9%
2006
Stage at
Diagnosis
White Females Black Females
In Situ 12.6% 14.0%
Localized 48.1% 30.2%
Regional 31.6% 44.2%
Distant 6.3% 7.0%
Unknown 1.5% 4.7%
2007
Stage at
Diagnosis
White Females Black Females
In Situ 15.5% 22.7%
Localized 53.4% 29.5%
Regional 22.8% 31.8%
Distant 5.9% 9.1%
Unknown 2.3% 6.8%
2008
Stage at
Diagnosis
White Females Black Females
In Situ 11.9% 8.8%
Localized 52.1% 38.6%
Regional 27.3% 40.4%
Distant 5.7% 8.8%
Unknown 3.1% 3.5%
2009
Stage at
Diagnosis
White Females Black Females
In Situ 20.2% 17.5%
Localized 47.1% 47.5%
Regional 25.6% 22.5%
Distant 4.9% 10.0%
Unknown 2.2% 2.5%
2010
Stage at
Diagnosis
White Females Black Females
In Situ 15.7% 25.5%
Localized 50.5% 42.6%
Regional 26.5% 21.3%
Distant 6.4% 8.5%
Unknown 1.0% 2.1%
Public Health District III
2003^
Stage at
Diagnosis
White Females Black Females
In Situ 11.1% 13.9%
Localized 43.1% 38.9%
Regional 31.9% 38.9%
Distant 2.8% 1.4%
Unknown 11.1% 6.9%
2004
Stage at
Diagnosis
White Females Black Females
In Situ 18.8% 10.1%
Localized 31.3% 35.4%
Regional 35.9% 38.0%
Distant 4.7% 6.3%
Unknown 9.4% 10.1%
2005
Stage at
Diagnosis
White Females Black Females
In Situ 13.6% 10.0%
Localized 50.0% 40.0%
Regional 30.3% 24.3%
Distant 6.1% 10.0%
Unknown 0.0% 15.7%
2006
Stage at
Diagnosis
White Females Black Females
In Situ 21.7% 12.7%
Localized 43.5% 38.0%
Regional 24.6% 35.4%
Distant 7.2% 10.1%
Unknown 2.9% 3.8%
2007
Stage at
Diagnosis
White Females Black Females
In Situ 21.7% 11.9%
Localized 42.0% 36.9%
Regional 21.7% 32.1%
Distant 5.8% 13.1%
Unknown 8.7% 6.0%
2008
Stage at
Diagnosis
White Females Black Females
In Situ 17.9% 14.7%
Localized 47.4% 33.9%
Regional 26.9% 38.5%
Distant 3.8% 9.2%
Unknown 3.8% 3.7%
2009
Stage at
Diagnosis
White Females Black Females
In Situ 11.0% 20.8%
Localized 52.1% 38.6%
Regional 30.1% 27.7%
Distant 4.1% 5.9%
Unknown 2.7% 6.9%
2010
Stage at
Diagnosis
White Females Black Females
In Situ 17.2% 11.5%
Localized 50.0% 45.1%
Regional 27.6% 32.7%
Distant 5.2% 6.2%
Unknown 0.0% 4.4%
Public Health District IV
2003^
Stage at
Diagnosis
White Females Black Females
In Situ 19.5% 12.5%
Localized 50.0% 25.0%
Regional 25.4% 59.4%
Distant 3.4% 3.1%
Unknown 1.7% 0.0%
2004
Stage at
Diagnosis
White Females Black Females
In Situ 16.2% 16.9%
Localized 54.3% 49.2%
Regional 25.7% 27.7%
Distant 1.9% 4.6%
Unknown 1.9% 1.5%
2005
Stage at
Diagnosis
White Females Black Females
In Situ 8.3% 7.4%
Localized 54.6% 48.1%
Regional 27.8% 38.9%
Distant 5.6% 1.9%
Unknown 3.7% 3.7%
2006
Stage at
Diagnosis
White Females Black Females
In Situ 12.6% 6.5%
Localized 52.3% 51.6%
Regional 27.0% 35.5%
Distant 3.6% 6.5%
Unknown 4.5% 0.0%
2007
Stage at
Diagnosis
White Females Black Females
In Situ 18.3% 16.4%
Localized 50.0% 34.3%
Regional 20.0% 43.3%
Distant 5.8% 4.5%
Unknown 5.8% 1.5%
2008
Stage at
Diagnosis
White Females Black Females
In Situ 14.3% 17.2%
Localized 53.8% 45.3%
Regional 22.7% 26.6%
Distant 5.9% 6.3%
Unknown 3.4% 4.7%
2009
Stage at
Diagnosis
White Females Black Females
In Situ 10.3% 11.1%
Localized 55.1% 45.8%
Regional 29.9% 26.4%
Distant 4.7% 13.9%
Unknown 0.0% 2.8%
2010
Stage at
Diagnosis
White Females Black Females
In Situ 14.3% 6.8%
Localized 53.6% 42.4%
Regional 26.4% 44.1%
Distant 5.0% 6.8%
Unknown 0.7% 0.0%
Public Health District V
2003^
Stage at
Diagnosis
White Females Black Females
In Situ 21.9% 11.6%
Localized 47.2% 37.0%
Regional 23.9% 38.2%
Distant 4.3% 9.8%
Unknown 2.7% 3.5%
2004
Stage at
Diagnosis
White Females Black Females
In Situ 17.6% 20.8%
Localized 48.0% 38.7%
Regional 28.4% 30.2%
Distant 3.4% 6.1%
Unknown 2.7% 4.2%
2005
Stage at
Diagnosis
White Females Black Females
In Situ 16.9% 16.3%
Localized 49.3% 39.8%
Regional 29.1% 34.4%
Distant 2.9% 5.4%
Unknown 1.8% 4.1%
2006
Stage at
Diagnosis
White Females Black Females
In Situ 17.3% 13.8%
Localized 50.0% 42.9%
Regional 28.2% 30.2%
Distant 2.6% 9.5%
Unknown 1.9% 3.7%
2007
Stage at
Diagnosis
White Females Black Females
In Situ 19.0% 14.2%
Localized 47.9% 47.6%
Regional 27.1% 29.2%
Distant 3.9% 5.7%
Unknown 2.1% 3.3%
2008
Stage at
Diagnosis
White Females Black Females
In Situ 16.2% 15.5%
Localized 55.0% 38.6%
Regional 24.5% 31.4%
Distant 3.1% 11.8%
Unknown 1.2% 2.7%
2009
Stage at
Diagnosis
White Females Black Females
In Situ 18.5% 16.3%
Localized 51.1% 42.1%
Regional 24.9% 31.3%
Distant 3.2% 7.1%
Unknown 2.2% 3.3%
2010
Stage at
Diagnosis
White Females Black Females
In Situ 20.1% 22.9%
Localized 49.4% 36.7%
Regional 24.7% 32.7%
Distant 4.3% 5.7%
Unknown 1.5% 2.0%
Public Health District VI
2003^
Stage at
Diagnosis
White Females Black Females
In Situ 19.6% 6.4%
Localized 45.5% 57.4%
Regional 26.8% 29.8%
Distant 4.5% 4.3%
Unknown 3.6% 2.1%
2004
Stage at
Diagnosis
White Females Black Females
In Situ 14.2% 15.5%
Localized 49.1% 44.8%
Regional 29.2% 37.9%
Distant 5.7% 1.7%
Unknown 1.9% 0.0%
2005
Stage at
Diagnosis
White Females Black Females
In Situ 17.0% 21.2%
Localized 42.6% 36.5%
Regional 31.9% 40.4%
Distant 6.4% 0.0%
Unknown 2.1% 1.9%
2006
Stage at
Diagnosis
White Females Black Females
In Situ 14.9% 9.5%
Localized 46.5% 33.3%
Regional 29.8% 44.4%
Distant 7.9% 11.1%
Unknown 0.9% 1.6%
2007
Stage at
Diagnosis
White Females Black Females
In Situ 20.6% 8.3%
Localized 43.0% 51.7%
Regional 32.7% 26.7%
Distant 2.8% 10.0%
Unknown 0.9% 3.3%
2008
Stage at
Diagnosis
White Females Black Females
In Situ 13.2% 10.9%
Localized 50.7% 45.3%
Regional 31.6% 37.5%
Distant 2.9% 3.1%
Unknown 1.5% 3.1%
2009
Stage at
Diagnosis
White Females Black Females
In Situ 18.7% 12.5%
Localized 55.3% 46.4%
Regional 20.3% 33.9%
Distant 4.1% 5.4%
Unknown 1.6% 1.8%
2010
Stage at
Diagnosis
White Females Black Females
In Situ 10.8% 18.9%
Localized 51.4% 45.3%
Regional 32.4% 28.3%
Distant 4.5% 3.8%
Unknown 0.9% 3.8%
Public Health District VII
2003^
Stage at
Diagnosis
White Females Black Females
In Situ 15.2% 17.3%
Localized 55.7% 40.4%
Regional 20.3% 32.7%
Distant 2.5% 9.6%
Unknown 6.3% 0.0%
2004
Stage at
Diagnosis
White Females Black Females
In Situ 11.8% 14.0%
Localized 57.6% 32.0%
Regional 23.5% 40.0%
Distant 4.7% 12.0%
Unknown 2.4% 2.0%
2005
Stage at
Diagnosis
White Females Black Females
In Situ 11.0% 9.8%
Localized 39.7% 35.3%
Regional 35.6% 35.3%
Distant 5.5% 9.8%
Unknown 8.2% 9.8%
2006
Stage at
Diagnosis
White Females Black Females
In Situ 17.5% 17.0%
Localized 53.8% 35.8%
Regional 22.5% 41.5%
Distant 3.8% 3.8%
Unknown 2.5% 1.9%
2007
Stage at
Diagnosis
White Females Black Females
In Situ 11.5% 17.5%
Localized 50.0% 44.4%
Regional 26.0% 23.8%
Distant 7.3% 11.1%
Unknown 5.2% 3.2%
2008
Stage at
Diagnosis
White Females Black Females
In Situ 12.7% 7.0%
Localized 55.6% 56.1%
Regional 19.0% 19.3%
Distant 7.9% 12.3%
Unknown 4.8% 5.3%
2009
Stage at
Diagnosis
White Females Black Females
In Situ 12.3% 7.4%
Localized 43.2% 42.6%
Regional 37.0% 39.7%
Distant 3.7% 7.4%
Unknown 3.7% 2.9%
2010
Stage at
Diagnosis
White Females Black Females
In Situ 13.5% 20.8%
Localized 62.2% 38.9%
Regional 20.3% 31.9%
Distant 4.1% 8.3%
Unknown 0.0% 0.0%
Public Health District VIII
2003^
Stage at
Diagnosis
White Females Black Females
In Situ 14.8% 23.5%
Localized 54.1% 35.3%
Regional 24.4% 31.4%
Distant 3.7% 5.9%
Unknown 3.0% 3.9%
2004
Stage at
Diagnosis
White Females Black Females
In Situ 12.7% 11.5%
Localized 50.9% 42.3%
Regional 30.1% 36.5%
Distant 4.6% 1.9%
Unknown 1.7% 7.7%
2005
Stage at
Diagnosis
White Females Black Females
In Situ 13.6% 11.9%
Localized 53.1% 38.1%
Regional 26.5% 40.5%
Distant 3.4% 9.5%
Unknown 3.4% 0.0%
2006
Stage at
Diagnosis
White Females Black Females
In Situ 8.3% 11.8%
Localized 50.8% 52.9%
Regional 29.5% 32.4%
Distant 6.1% 2.9%
Unknown 5.3% 0.0%
2007
Stage at
Diagnosis
White Females Black Females
In Situ 16.6% 15.4%
Localized 43.3% 46.2%
Regional 29.9% 28.8%
Distant 7.6% 7.7%
Unknown 2.5% 1.9%
2008
Stage at
Diagnosis
White Females Black Females
In Situ 14.6% 20.0%
Localized 53.0% 41.8%
Regional 28.6% 29.1%
Distant 1.6% 5.5%
Unknown 2.2% 3.6%
2009
Stage at
Diagnosis
White Females Black Females
In Situ 15.9% 16.7%
Localized 51.6% 45.5%
Regional 24.2% 28.8%
Distant 6.0% 7.6%
Unknown 2.2% 1.5%
2010
Stage at
Diagnosis
White Females Black Females
In Situ 19.6% 18.8%
Localized 48.5% 36.2%
Regional 25.3% 34.8%
Distant 6.2% 7.2%
Unknown 0.5% 2.9%
Public Health District IX
2003^
Stage at
Diagnosis
White Females Black Females
In Situ 20.7% 26.7%
Localized 50.4% 42.2%
Regional 22.0% 24.4%
Distant 3.7% 4.4%
Unknown 3.3% 2.2%
2004
Stage at
Diagnosis
White Females Black Females
In Situ 16.0% 24.4%
Localized 43.7% 29.3%
Regional 30.4% 31.7%
Distant 3.0% 9.8%
Unknown 6.8% 4.9%
2005
Stage at
Diagnosis
White Females Black Females
In Situ 19.7% 25.0%
Localized 48.5% 43.8%
Regional 21.8% 22.9%
Distant 5.9% 4.2%
Unknown 4.2% 4.2%
2006
Stage at
Diagnosis
White Females Black Females
In Situ 16.0% 20.0%
Localized 42.8% 28.9%
Regional 31.3% 40.0%
Distant 5.3% 6.7%
Unknown 4.5% 4.4%
2007
Stage at
Diagnosis
White Females Black Females
In Situ 17.0% 18.2%
Localized 50.3% 50.9%
Regional 24.2% 18.2%
Distant 4.9% 12.7%
Unknown 3.6% 0.0%
2008
Stage at
Diagnosis
White Females Black Females
In Situ 17.1% 16.4%
Localized 51.7% 41.8%
Regional 23.3% 29.1%
Distant 4.5% 10.9%
Unknown 3.4% 1.8%
2009
Stage at
Diagnosis
White Females Black Females
In Situ 16.0% 22.6%
Localized 50.2% 34.0%
Regional 27.0% 34.0%
Distant 5.0% 7.5%
Unknown 1.9% 1.9%
2010
Stage at
Diagnosis
White Females Black Females
In Situ 17.4% 23.6%
Localized 57.0% 32.7%
Regional 19.8% 30.9%
Distant 4.1% 12.7%
Unknown 1.7% 0.0%
^Use caution when comparing 2003 data to later years.  The staging system changed between 2003 and 2004.
These data were collected by the Mississippi Cancer Registry which participates in the
National Program of Cancer Registries (NPCR) of the Centers for Disease Control and Prevention (CDC).
These data were generated and posted on 04/30/2013.